Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY5R | Q15761 | 1/20 | 0.33 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27819766 | 0.91 | KDM1A (0.33) | NPY5R | |
| SCHEMBL1704325 | 0.78 | CA1 (0.46) | NPY5RTBXAS1HTR1A | |
| SCHEMBL1703764 | 0.77 | CA1 (0.44) | NPY5RTBXAS1TBXA2RHTR1A | |
| SCHEMBL1705415 | 0.77 | NPY5R (0.34) | NPY5RTBXAS1TBXA2RHTR1A | |
| SCHEMBL10064188 | 0.77 | NPY5R (0.34) | NPY5RTBXAS1TBXA2RHTR1A | |
| Hydrochloric Acid SCHEMBL27202561 | 0.75 | LOXL2 (0.35) | NPY5RTBXAS1TBXA2RHTR1A | |
| SCHEMBL23181217 | 0.74 | CA1 (0.48) | NPY5RHTR1A | |
| SCHEMBL8934429 | 0.73 | MMP1 (0.36) | TBXA2R | |
| SCHEMBL2224796 | 0.72 | — | — | |
| SCHEMBL13301181 | 0.71 | MMP1 (0.38) | NPY5RTBXA2RHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2137187-A1 | PYRAZOLO [1,5-A]PYRIMIDINES AS INHIBITORS OF STEAROYL-COA DESATURASE | Inovacia AB (SE) | 2009-12-30 | — | — | EP | disclosed |
| US-20080255153-A1 | New compounds | BIOVITRUM AB (PUBL) (SE) | 2008-10-16 | — | — | US | disclosed |
| WO-2008116898-A1 | PYRAZOLO [1,5-A]PYRIMIDINES AS INHIBITORS OF STEAROYL-COA DESATURASE | BIOVITRUM AB (PUBL) (SE) | 2008-10-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080255153-A1 | New compounds | SCD, SCD5, FADS2 | NPY5R 1566/4885TBXAS1 202/4885TBXA2R 1732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.